These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9010371)

  • 1. Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies.
    Barry HC; Ebell MH; Hickner J
    J Fam Pract; 1997 Jan; 44(1):49-60. PubMed ID: 9010371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of urinary tract infection in general practice: a cost-effectiveness analysis.
    Fenwick EA; Briggs AH; Hawke CI
    Br J Gen Pract; 2000 Aug; 50(457):635-9. PubMed ID: 11042915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric treatment of uncomplicated UTI in women: wasting money when more is not better.
    Kahan NR; Chinitz DP; Waitman DA; Kahan E
    J Clin Pharm Ther; 2004 Oct; 29(5):437-41. PubMed ID: 15482387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
    Le TP; Miller LG
    Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Office management of suspected UTI.
    Buds MS; Newton WP
    J Fam Pract; 1997 Apr; 44(4):342-3. PubMed ID: 9108828
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points.
    Lammers RL; Gibson S; Kovacs D; Sears W; Strachan G
    Ann Emerg Med; 2001 Nov; 38(5):505-12. PubMed ID: 11679861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
    Bradley MS; Beigi RH; Shepherd JP
    Am J Obstet Gynecol; 2019 Nov; 221(5):505.e1-505.e7. PubMed ID: 31055032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All dysuria is local. A cost-effectiveness model for designing site-specific management algorithms.
    Rothberg MB; Wong JB
    J Gen Intern Med; 2004 May; 19(5 Pt 1):433-43. PubMed ID: 15109341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of an updated guideline for the empiric treatment of uncomplicated urinary tract infection in women.
    Kahan NR; Kahan E; Waitman DA; Chinitz DP
    Isr Med Assoc J; 2004 Oct; 6(10):588-91. PubMed ID: 15473583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A decision analysis model in laboratory medicine--appropriate usage of microbiological examination in women with dysuria].
    Inoue Y
    Rinsho Byori; 1990 May; 38(5):587-92. PubMed ID: 2199709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
    Phillips S; MacDougall C; Holdford DA
    Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of competing strategies for the treatment of pediatric empyema.
    Cohen E; Weinstein M; Fisman DN
    Pediatrics; 2008 May; 121(5):e1250-7. PubMed ID: 18450867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions.
    Mrus JM; Biro FM; Huang B; Tsevat J
    Arch Pediatr Adolesc Med; 2003 Jul; 157(7):696-702. PubMed ID: 12860793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
    Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
    J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of telephone management of suspected urinary tract infections in women.
    Barry HC; Hickner J; Ebell MH; Ettenhofer T
    J Fam Pract; 2001 Jul; 50(7):589-94. PubMed ID: 11485707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.